In 2013, we changed the name of this journal to Artificial Cells, Nanomedicine and Biotechnology .Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:artificial cellsblood substitutes and oxygen therapeuticsnanotechnology, nanobiotecnology, nanomedicinetissue engineeringstem cellsbioencapsulationmicroencapsulation and nanoencapsulationmicroparticles and nanoparticlesliposomescell therapy and gene therapyenzyme therapydrug delivery systemsbiodegradable and biocompatible polymers for scaffolds and carriersbiosensorsimmobilized enzymes and their usesother biotechnological and nanobiotechnological approachesRapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.
2013年，我们将本杂志更名为“人造细胞”、“纳米医学”和“生物技术”。人工细胞、纳米医学和生物技术涵盖了跨学科研究和应用的前沿领域，将人工细胞、纳米技术、纳米生物技术、生物技术、分子生物学、生物封装、新型载体、干细胞和组织工程相结合。重点是以下主题的基础研究、应用研究和临床和工业应用：人工细胞血液替代品和氧气疗法纳米技术、纳米生物技术、纳米医学组织工程干细胞生物胶囊化微胶囊化和纳米封装微粒和纳米粒子脂质体细胞疗法和基因疗法酶疗法药物输送系统支架和载体用可生物降解和生物相容性聚合物生物传感器固定化酶及其应用其他生物技术和纳米生物技术方法现代研究的快速发展不能孤立地进行，而是以各种新颖方法的综合运用为基础。如上所述，涉及新颖方法的跨学科研究已经彻底改变了这一领域，并取得了快速发展。本杂志旨在将这些不同的、现代的和未来的方法结合在一起，为学术界、临床界和工业界提供更大的发展空间。
投稿咨询
